FeesSafety
Pluang+

newcleo reports Q3 2026 revenue up 26%, advances reactor prototype and fuel projects, expands 10 GW pipeline

Company Fundamentals
18 Nov 2026, 14:05 WIB
GlobeNewsWire
View Source
Bullish
newcleo reports Q3 2026 revenue up 26%, advances reactor prototype and fuel projects, expands 10 GW pipeline

newcleo plc announced a 26% revenue increase to €10 million in Q3 2026, driven by engineering and equipment sales. The company completed key installations at its 10 MWth PRECURSOR reactor prototype in Italy and inaugurated a new fuel testing center in France. It expanded its commercial pipeline to 10 GW and secured regulatory progress for its MOX fuel facility. Cash reserves rose to €233.4 million, supporting ongoing construction, regulatory efforts, and commercial growth. The company aims to complete reactor commissioning by mid-2027 and advance its nuclear fuel manufacturing capabilities.

newcleo plc's third quarter 2026 update provides context for readers interested in industrial developments. For readers following the Industrials sector, here is Pluang's market snapshot as of Nov 18, 2026 19:12 WIB: 75 of 135 priced US Industrials stocks rose today. Notable movers include FIX at USD 1,134.06 with a 1-day change of +3.19%, FPS at USD 21.87 with +3.16%, and AXON at USD 308.00 with +3.15%.

More News

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft's stock fell 2.27% to $506.24 following global outages affecting its Copilot, Teams, and Outlook services. The outages, attributed to server issues rather than cyberattacks, raised concerns amid broader software sector weakness. Oppenheimer...

Market News
Bearish
49 minutes ago
Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target Corporation reported earnings per share of $2.65, beating estimates of $2.08, and revenue of $27.1 billion, surpassing the $26.5 billion forecast. The company achieved its strongest quarterly sales growth in about five years, with net sales up...

Company Fundamentals
Bullish
55 minutes ago
Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics announced its participation in the Piper Sandler 38th Annual Healthcare Conference from December 1-3, 2026, in New York City. CEO Daniel Barber will present on December 2 at 10:30 am ET, with one-on-one investor meetings schedu...

Market News
Neutral
1 hour ago
Raymond James upgrades Charles Schwab to Strong Buy as client assets hit $13.27T in Oct 2026

Raymond James upgrades Charles Schwab to Strong Buy as client assets hit $13.27T in Oct 2026

Raymond James upgraded Charles Schwab to Strong Buy following strong growth in October 2026. Client assets rose 12% year over year to $13.27 trillion, with core net new assets surging 50% to $66.5 billion, a record for the month. Schwab also opened 4...

Analyst Insights
Bullish
2 hours ago
SDVerse named CES Innovation Awards 2027 Honoree for AI-powered automotive software marketplace.

SDVerse named CES Innovation Awards 2027 Honoree for AI-powered automotive software marketplace.

SDVerse, a B2B automotive software marketplace founded by General Motors, Magna, and Wipro, was honored with a CES Innovation Award 2027 in the Enterprise Tech category. The platform uses AI and standardized technical data to help automakers and supp...

Others
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App